3'5'-cyclic nucleotide phosphodiesterase, catalytic domain superfamily
Short name | PDEase_catalytic_dom_sf |
Overlapping entries |
Description
References
1.Type 3 phosphodiesterase inhibitors may be protective against cerebrovascular events in patients with claudication. Stone WM, Demaerschalk BM, Fowl RJ, Money SR. 17, 129-33, (2008). View articlePMID: 18436153
2.Phosphodiesterase 5 inhibition in essential hypertension. Ghiadoni L, Versari D, Taddei S. Curr. Hypertens. Rep. 10, 52-7, (2008). View articlePMID: 18367027
3.Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma. Field SK. 17, 811-8, (2008). View articlePMID: 18447606
4.Photoreceptor Phosphodiesterase (PDE6): Structure, Regulatory Mechanisms, and Implications for Treatment of Retinal Diseases. Cote RH, Gupta R, Irwin MJ, Wang X. Adv Exp Med Biol 1371, 33-59, (2022). View articlePMID: 34170501
GO terms
biological process
molecular function
cellular component
- None
Cross References
Contributing Member Database Entry
- CATH-Gene3D:G3DSA:1.10.1300.10